Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 6

    1.

    Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

    Galanello R, Piga A, Forni GL, Bertrand Y, Foschini ML, Bordone E, Leoni G, Lavagetto A, Zappu A, Longo F, Maseruka H, Hewson N, Sechaud R, Belleli R, Alberti D.

    Haematologica. 2006 Oct;91(10):1343-51.PMID: 17018383 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Developmental changes in patterns of expression of tenascin-C variants in the human cornea.

    Maseruka H, Ridgway A, Tullo A, Bonshek R.

    Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4101-7.PMID: 11095602 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Human herpesviruses in the cornea.

    Kaye SB, Baker K, Bonshek R, Maseruka H, Grinfeld E, Tullo A, Easty DL, Hart CA.

    Br J Ophthalmol. 2000 Jun;84(6):563-71.PMID: 10837377 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Tenascin-cytotactin (TN-C) variants in pseudophakic/aphakic bullous keratopathy corneas.

    Maseruka H, Ataullah SM, Zardi L, Tullo AB, Ridgway AE, Bonshek RE.

    Eye (Lond). 1998;12 ( Pt 4):729-34.PMID: 9850274 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tenascin-C expression in normal, inflamed, and scarred human corneas.

    Maseruka H, Bonshek RE, Tullo AB.

    Br J Ophthalmol. 1997 Aug;81(8):677-82.PMID: 9349157 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Immunohistochemical appearance of corticosteroid contact hypersensitivity reactions.

    Wilkinson SM, Andrew SM, Maseruka H, Beck MH.

    Contact Dermatitis. 1994 Nov;31(5):304-7.PMID: 7532558 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...